AnHorn Medicines
Valuation
$5M
2024 Revenue
$1.7M
Funding
$0
Team
11
Founded
2020
How AnHorn Medicines grew AnHorn Medicines to $1.7M revenue with a 11 person team in 2024.
AnHorn Medicines is a novel drug discovery company with a strong pipeline, offering therapies that target and degrade disease-related proteins. Our mission is to develop new class of drugs BIGPRO® (Bi-functional liGand induced PROteolysis) under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases. We focus on novel therapies for cancer, neurodegeneration, and aging diseases. We are turning innovation into new therapeutics – new opportunities to target difficult-to-treat diseases and diseases plagued by drug resistance.
Last updated
AnHorn Medicines Revenue
In 2024, AnHorn Medicines's revenue reached $1.7M. Since its launch in 2020, AnHorn Medicines has shown consistent revenue growth.
| Year | Milestone |
|---|---|
| 2024 | AnHorn Medicines Hit $1.7m revenue in June 2024 |
| 2020 | Launched with $0 revenue |
AnHorn Medicines Valuation, Funding Rounds
AnHorn Medicines's most recent disclosed valuation is $5M.
AnHorn Medicines is a bootstrapped SaaS startup. Founded in 2020, AnHorn Medicines has grown to $1.7M in revenue without raising any venture capital or outside funding.
As a self-funded SaaS company, AnHorn Medicines has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold |
|---|
AnHorn Medicines Employees & Team Size
AnHorn Medicines employs approximately 11 people as of 2026.
AnHorn Medicines has 11 total employees in different roles and functions.
| Year | Milestone |
|---|---|
| 2024 | Reached 11 employees (June 2024) |
Customers
We do not have customer count information for AnHorn Medicines yet.
Frequently Asked Questions about AnHorn Medicines
What is AnHorn Medicines's revenue?
AnHorn Medicines generates $1.7M in revenue.
How much funding does AnHorn Medicines have?
AnHorn Medicines raised $0.
How many employees does AnHorn Medicines have?
AnHorn Medicines has 11 employees.
Where is AnHorn Medicines headquarters?
AnHorn Medicines is headquartered in Taipei City, Taipei, Taiwan.
People Also Viewed
MishiPay
Developer of a mobile self-checkout technology designed to make online payments. The company's technology allows shoppers to pick up a product they wish to buy, scan the barcode and automatically pay with their phone, enabling shoppers to make secure cashless payments via a virtual mobile payment platform and save time by not waiting in queues.
DocLens.ai
Agentic AI Workflow for Complex Claims and Legal
Treiner
TREINER (treiner.com.au) is an Australian & New Zealand based holistic football coach booking marketplace offering a vast range of coaches in different fields & specialisations at locations, budget and experience to suit football players of all ages and abilities, whether you are a young player starting out, a youth player looking to move to the next level or a professional player looking for some specialist unbiased and objective training and feedback away from a club environment to help you gain your next contract.
PetaGene
Operator of a technology company intended to develop genomics data compression and acceleration software. The company's compression software addresses challenges caused by growing volumes of genomics data and transparently integrates it with existing storage infrastructure and bioinformatics pipelines, offering clients with a set of software tools that reduce the size and cost of NGS data for storage and transfer.
dotin
Developer of an artificial intelligence platform designed to capture digital personality fingerprint. The company's business to business, SaaS platform combines psychology, structured/unstructured social and/or enterprise data, and machine learning to identify subconscious motivators and leverage these vital personality insights to improve business outcomes and the workplace itself.
LiquidText
Developer of a computer-based active reading system software. The company offers a fluid document representation built on multi-touch input interaction techniques designed to facilitate the activities of active reading including manipulation of presentation of content, control what content is displayed and where, creation of annotations and other structures on top of content, as well as navigation through content.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .